Turkish Version of Helkimo Clinical Dysfunction Index
ConditionTemporomandibular Disorder (TMD)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorSevgi Medical Center
About this trial
This study aimed to translate the Helkimo Clinical Dysfunction Index (HCDI) into Turkish and to test its validity and reliability as an outcome measurement method in individuals with temporomandibular dysfunction (TMD). The study included 40 patients. Participants' pain intensity and range of jaw movement were measured, followed by the administration of the HDCI, the Fonseca Anamnestic Index (FAI), and the Mandibular Function Impairment Questionnaire (MFIQ). For test-retest reliability, the same questionnaire was administered again to the same patients two weeks later, and the FAI was used to test the validity of the questionnaire.
Eligibility criteria
Qualifiers
Being between 18 and 60 years of age and having been diagnosed with TMB,
The person must be a volunteer to participate in the study,
The native language must be Turkish.
Disqualifiers
Having a history of malignant conditions, trauma, or surgery in the cranial and cervical region,
Inability to cooperate,
Regular use of analgesic and anti-inflammatory drugs,
Having dentofacial anomalies,
Trial design
Treatments tested in this trial
- Turkish Version of Helkimo Clinical Dysfunction Index and Accompanying Scales
Treatment groups
48 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov